Is ALHC Stock Worth Buying After a Big Rally and Higher Forecasts
Alignment Healthcare's improved profits, raised 2026 outlook and stronger cash flow support the bull case, but its big rally and richer valuation raise the buy bar.
Alignment Healthcare Outlook as MA Growth Fuels Margin Gains in 2026
Alignment Healthcare's Medicare Advantage growth, quality ratings and automation gains are lifting profitability, but 2026 execution risks remain.
Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?
Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Alignment Healthcare, Inc. (ALHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Alignment Healthcare, Inc. (ALHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Boost Your Portfolio Returns With These 4 Top-Performing Liquid Stocks
ALHC, TOST, TTMI and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Down 25.5% in 4 Weeks, Here's Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Alignment Healthcare (ALHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why Alignment Healthcare (ALHC) is Poised for a Turnaround After Losing 31.0% in 4 Weeks
Alignment Healthcare (ALHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Alignment Healthcare, Inc. (ALHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Alignment Healthcare, Inc. (ALHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Alignment Healthcare CEO Adds Chairman Role As Medicare Business Grows
Alignment Healthcare is bolstering its management team, adding the chairman's role to top executive and founder John Kao's duties while promoting several other executives as the company sells more Medicare Advantage plans.
Can Alignment Healthcare (ALHC) Climb 32.61% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 32.6% in Alignment Healthcare (ALHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
